At 200 mcg per dose, that is only 10 doses per vial
Laboratory research record on Survodutide [PMID: 41187967] PubMed laboratory record discussing Survodutide in a research context
Angew Chem Int Ed 46(48):92489252
Cost-benefit analysis: using peptides near expiration Should you use peptides at day 35
In addition, GPX4 inhibitors remain challenging to use in vivo owing to their poor bioavailability, and pharmacological inhibition of GPX4 carries a substantial risk of systemic toxicity, as demonstrated in GPX4 knockout mouse models 25,26,27 Thus, modulating the CoQ 10 redox cycle, either by inhibiting ubiquinol (CoQ 10 H 2 , reduced) formation or altering oxidoreductase activity, has emerged as an alternative therapeutic strategy for ferroptosis-based cancer therapy
It's just not the intervention the marketing suggests